TribLIVE

| Home

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan to buy drug plant in India

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

Thursday, Oct. 18, 2012, 12:01 a.m.
 

Mylan Inc. agreed to buy an Indian drug manufacturing plant for about $32.5 million, the Cecil-based company said on Wednesday.

Owned by SMS Pharmaceuticals Ltd., the plant specializes in making cancer medications and the active ingredients for cancer drugs.

“The acquisition of this facility will support several of Mylan's strategic growth drivers, particularly expansion of our institutional business,” the company said in a statement.

Generic drugmaker Mylan's institutional subsidiary sells various pharmaceutical products directly to group purchasing organizations, wholesalers, hospitals, long-term care facilities and other large buyers.

Mylan, through its India-based subsidiary Mylan Laboratories Ltd., operates nine pharmaceutical manufacturing plants in India and China. It acquired the Indian operations in 2007 when it purchased Matrix Laboratories, one of the world's largest producers of active pharmaceutical ingredients.

Mylan expects the deal for the SMS facility to close in the first quarter of next year.

In August, Mylan started commercial operations in India by selling products that treat HIV and AIDS and has said it wants to expand in that country.

Mylan, the world's third-largest generic drugmaker by sales, will report third-quarter financial results next week.

Mylan stock closed at $24.28, up 24 cents.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

Add Alex Nixon to your Google+ circles.

Subscribe today! Click here for our subscription offers.

 

 

 


Show commenting policy

Most-Read Stories

  1. Happ’s strong start, Ramirez’s homer pace Pirates past Rockies
  2. Pitt star running back Conner remains grounded despite success
  3. Big plays cost Steelers defense in 43-19 preseason loss at Bills
  4. Steelers notebook: Tomlin mum on Bryant suspension
  5. College football preview: ACC
  6. Rossi: Beleaguered Steelers need MVP from Big Ben
  7. Biertempfel: Pittsburgh native faced quick learning curve as Marlins GM
  8. Unlike during his time at Florida, Ohio State’s Meyer learning to enjoy his success
  9. Architecture: Pittsburgh history in 10 houses
  10. Exclusive to the Trib: Lift the oil export ban? Think again
  11. Pitt’s cancer institute marks 30 years with eye toward future